Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

MASSACHUSETTS GENERAL

G. L. Brownell, "New Imaging Systems," iu Nuclear Medicine Technical Progress Report, Massachusetts General Hospital, Boston, Mass., July 1, 1974-Apr. 1,1975. [Pg.282]

Cambridge, and Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts... [Pg.43]

Cato Laurencin Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, Massachusetts Department of Orthopedic Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts... [Pg.357]

A detailed clinical history, past medical and surgical history, medications, allergies, laboratory work-up, physical examination, and NIHSS should be obtained as quickly as possible for assessment of inclusion and exclusion criteria for lAT. Table 4.1 lists the criteria for catheter-based reperfusion therapy currently in place at the Massachusetts General Hospital (Table 4.1 see also www.acutestroke.com for updated criteria). [Pg.71]

TABLE 4.1 Criteria for Catheter-based Reperfnsion Therapy Currently in Place at the Massachusetts General Hospital. [Pg.72]

Hari G. GARG,t Laboratory for Carbohydrate Research, Departments of Biological Chemistry and Medicine, Harvard Medical School, and Massachusetts General Hospital, Boston, Massachusetts 02114 (135)... [Pg.473]

Emmett V. Schmidt Laboratory of Tumor Biology, MGH Cancer Center, Massachusetts General Hospital, Charelestown, MA 02129, USA... [Pg.261]

Based on their corporate experience in supporting their own research and development projects as well as a number of government-sponsored activities, the development of scientific software at BBN grew out of a long history of support of a variety of scientific applications. For example, in the 1960 s, BBN developed a hospital information system for Massachusetts General Hospital which used an early minicomputer, the PDP-1, to support clinical research activities. Under the sponsorship of the National Institutes of Health, they developed a system called PROPHET (1) which provides a... [Pg.23]

Diethyl ether was first used as a surgical anesthetic by C. W. Long of Jefferson, Georgia, in 1842 and shortly after by J. C. Waren of the Massachusetts General Hospital in Boston. [Pg.411]

Harvard Medical School, Massachusetts General Hospital, Mass General Institute for Neurodegenerative Disorders, Charlestown, Massachusetts 02129... [Pg.3]

Assistant Professor of Neurology, Harvard Medical School Massachusetts General Hospital 114 16th Street... [Pg.1007]

Instructor in Anesthesia, Harvard Medical School Neural Plasticity Research Group, Department of Anesthesia and Critical Care Massachusetts General Hospital 149 13 th Street... [Pg.1008]

Department of Anesthesia and Critical Care Massachusetts General Hospital 149 13th Street... [Pg.1012]

Pauling L. Molecular structure and disease. October 9,1958. Lowell Lecture, Massachusetts General Hospital, Boston, Massachusetts. Available at http //osulibrary. oregonstate.edu/specialcollections/coll/pauling/blood/notes/1958s2.8-ts-02.html. Accessed May 28,2013. [Pg.34]

Franklin D. Roosevelt, Jr., his mother said, lay desperately ill in Massachusetts General Hospital. The doctors thought he might be dying. An infection in his throat had spread to his sinuses and was now, carried through his blood, engulfing his body. [Pg.118]

Correspondence to BAR 414, Wellman Center for Photomedicine, Massachusetts General Hospital, 40 Blossom Street, Boston, MA 02114, USA Email hamblin helix.mgh.harvard.edu... [Pg.79]

The NIH and the pharmaceutical industry have formed a new partnership to overcome barriers to early-phase clinical trials. The Secretary of Health and Human Services, Tommy Thompson, announced on July 9, 2003 grant awards for six cancer centers involved in a unique public-private partnership. Five pharmaceutical companies together with NCI put forth a total of 5.7 million for this partnership. Institutions receiving the funding include Massachusetts General Hospital University of Colorado Health Sciences Center Washington University, St. Louis University of Pittsburgh Cancer Institute University of California, Davis Cancer Center and Ohio State University Comprehensive Cancer Center (http //WWW. bms.com/news/other/data/pf other.news.385 5. html). [Pg.461]

An effective anesthetic agent must be easy to use, quickly render the patient unconscious, and not produce any toxicity. Dr. William T. G. Morton first publicly demonstrated the use of ether as an effective anesthetic agent at the Massachusetts General Hospital on 16 October 1846 before a crowd of skeptical physicians. Raymundus Lullius, a Spanish chemist, discovered ether (CH3CH2)20 in 1275. Its hypnotic effects were soon appreciated (and enjoyed by some), but for many decades ether was only used to treat the occasional medical ailment. Even with ether, the success of surgical procedures did not improve until the introduction of antiseptic procedures and infection control some 20 years later. Ether was replaced by cyclopropane in 1929, which was replace by halothane in 1956. While anesthetic agents are desirable for the patient, exposure of hospital staff is highly undesirable and an important occupational consideration. [Pg.136]

Wright et al. from the Massachusetts General Hospital reported interesting results from their intensive trial of preoperative paclitaxel, cisplatin, and 5-fluorouracil with hyperfractionated radiation (total tumor dose of 58.5 Gy and 45 Gy to the mediastinum)... [Pg.79]

In 1993, investigators at the Massachusetts General Hospital (MGH) published the results of an institutional study, which became the model for several subsequent trials (67). In this first report, 53 patients (T2-4, NXMO) underwent maximal TURBT, followed by two cycles of CMV, then 4000 cGy + two cycles of single-agent cisplatin. Patients then underwent endoscopic reevaluation and those who had an incomplete response to therapy and who were surgical candidates underwent cystectomy, whereas complete responders were consolidated with an additional 2480 cGy and one additional cycle of cisplatin. Following 11 dropouts, 42 patients completed therapy and there was... [Pg.296]


See other pages where MASSACHUSETTS GENERAL is mentioned: [Pg.88]    [Pg.215]    [Pg.246]    [Pg.247]    [Pg.247]    [Pg.247]    [Pg.473]    [Pg.507]    [Pg.461]    [Pg.6]    [Pg.78]    [Pg.134]    [Pg.263]    [Pg.27]    [Pg.133]    [Pg.273]    [Pg.275]   


SEARCH



Massachusetts

© 2024 chempedia.info